2792TiP A phase Ib/II study of gocatamig (MK-6070; HPN328) and ifinatamab deruxtecan for relapsed/refractory extensive-stage small cell lung cancer (ES-SCLC)
2025 · Annals of Oncology · 1 citations
https://doi.org/10.1016/j.annonc.2025.08.3403
J
J.C. Benítez Montañez
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
19
Papers
9
Citations
1
h-index
0
i10-index
J.C. Benítez Montañez is an academic researcher from Hospital Clínico San Carlos. The author has contributed to research in topics: Myasthenia Gravis and Thymoma & Lung Cancer Treatments and Mutations & Pituitary Gland Disorders and Treatments. The author has an h-index of 1, co-authored 17 publications.
Papers by this author
works1294P Non-adenocarcinoma histology in patients with RET+ lung cancer: Response to RET-inhibitors and survival from the RET-MAP registry
2024 · Annals of Oncology · 0 citations
https://doi.org/10.1016/j.annonc.2024.08.1351
2062eP Efficacy of second-line carboplatin plus pemetrexed after osimertinib in EGFR-mutant advanced NSCLC patients: An international real-world analysis
2025 · Annals of Oncology · 0 citations
https://doi.org/10.1016/j.annonc.2025.08.2683
246P Acasunlimab monotherapy or with pembrolizumab in CPI-treated mNSCLC: Primary phase II results
2025 · Immuno-Oncology Technology · 0 citations
https://doi.org/10.1016/j.iotech.2025.101445
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat